Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 183   

Articles published

PFE 33.08 +1.24 (3.89%)
price chart
Pfizer Raised Prices on 133 Drugs This Year, And It's Not Alone
Pfizer Inc., the nation's biggest drugmaker, has raised prices on 133 of its brand-name products in the U.S. this year, according to research from UBS, more than three-quarters of which added up to hikes of 10 percent or more.
Pfizer Inc. (NYSE:PFE) is a Buy at Current Levels – Jim Cramer
Encouragingly, Pfizer Inc. (NYSE:PFE)'s well-established product portfolio will remain patent-protected for several more years.
Pfizer Inc (NYSE:PFE) Stock Improved to Overweight at Morgan Stanley from ...
Pfizer Inc (NYSE:PFE) Upgraded at Morgan Stanley to Overweight from Equal ...
Pfizer Inc. Announces Final Results of Exchange Offers
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (“Pfizer”) (NYSE: PFE) announced today the final results of its previously announced offers to exchange any and all validly tendered and accepted notes of each series listed in the table below (collectively, the ...
Watch List -Pfizer (PFE), Anworth Mortgage Asset (ANH), XenoPort (XNPT ...  Investor Wired
Pfizer Inc. (PFE) Raises Guidance Upon Hospira Acquisition
On Wednesday, Pfizer Inc. (NYSE:PFE) increased its full year 2015 guidance for revenue and adjusted earnings, driven by the company's acquisition of Hospira Inc. which was closed earlier this month.
Acquisition Of Hospira And Boosted Guidance Make Pfizer Inc. (NYSE:PFE) An ...  InvestCorrectly
Pfizer (PFE) Stock Closes Higher, Raises Full-Year Revenue, Earnings Forecasts
Pfizer Edges Outlook Higher to Factor in Hospira
Pfizer acquired smaller rival Hospira in a $16 billion deal that closed earlier this month. The acquisition is expected to transform the pharmaceutical company into a leading player in the emerging market for lower-priced knockoffs of costly biotech drugs.
Pfizer (PFE) Boosts FY15 Outlook Following Completion of Hospira Acquisition
Pfizer lifts outlook to factor in Hospira purchase  MarketWatch
Stocks to Watch: Tesla, Pfizer, Paychex, Campbell Soup
Among the companies with shares expected to trade actively in Wednesday's session are Tesla Motors Inc., Pfizer Inc. and Paychex Inc. Tesla launched its new Model X electric SUV Tuesday evening with CEO Elon Musk saying he had only one regret about ...
BIND Therapeutics Announces Pfizer Inc. Exercises Option to Advance ...
CAMBRIDGE, Mass., Sep 24, 2015 (BUSINESS WIRE) -- BIND Therapeutics, Inc. BIND, -3.59% a clinical-stage nanomedicine company developing targeted and programmable therapeutics called AccurinsTM, today announced that Pfizer Inc. exercised its ...
BIND Therapeutics Announces Pfizer Obtains License for Drug  Pharmaceutical Processing
Pfizer to develop cancer drug partnered with Cambridge biotech Bind  Boston Business Journal (blog)
No one injured in incident at Pfizer Inc. in Portage
PORTAGE, MI - No one was injured in an incident at Pfizer Inc.'s Portage Road facility over the weekend. The incident happened around 10 a.m.
Cramer Is Not A Buyer Of Royal Dutch Shell, Likes Pfizer
Jim Cramer said on CNBC's Mad Money that he has changed his mind on Royal Dutch Shell plc (ADR) (NYSE: RDS-A). He now thinks that it shouldn't be owned.
Pfizer Inc. To Lead Cancer Treatment Market
Pfizer Inc. (NYSE:PFE) is set to initiate as many as 20 new clinical trials for cancer treatments this year, which would be followed by many more in the years to come as the company plans to seek leadership position in the rapidly expanding cancer ...
Pfizer Says It Could Be Leader in Cancer With Many New Drugs  ABC News